Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20221206005205/en/MyMD-Pharmaceuticals%C2%AE-to-Present-Data-on-Oral-TNF-a-Inhibitor-MYMD-1%C2%AE-at-the-British-Society-for-Immunology-BSI-Congress-2022
Dec 6, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next